Filing Flows › Cryo Cell International (CCEL) › Q3 FY26 › vs Q2 FY26
Cryo Cell International (CCEL) Q3 FY26 vs Q2 FY26 (quarter over quarter)
Cryo Cell International's revenue rose $48K (+0.6%) from $7.8M in Q2 FY26 to $7.8M in Q3 FY26. The biggest changes: Public Banking +$89K (+190%); Processing and Storage Fees −$65K (-0.8%); Product +$25K (+174%). Operating margin 28.0% against 15.4% (+12.6 pts).
Cryo Cell International, Q3 FY26: revenue $7.8M (0% year over year), operating margin 28.0%, net earnings $1.3M, operating cash flow $1.1M. The chart draws each line against Q2 FY26, the increases inside each band.
Margins
| Q3 FY26 | Q2 FY26 | Change | |
|---|---|---|---|
| Operating margin | 28.0% | 15.4% | +12.6 pts |
| Net margin | 16.2% | 7.1% | +9.1 pts |
| Free cash flow margin | 13.3% | 23.3% | -10.0 pts |
Every line
| Line | Q3 FY26 | Q2 FY26 | Change | % |
|---|---|---|---|---|
| Processing and Storage Fees | $7.7M | $7.7M | −$65K | -0.8% |
| Public Banking | $135K | $46K | $89K | +190% |
| Product | $39K | $14K | $25K | +174% |
| Revenue | $7.8M | $7.8M | $48K | +0.6% |
| Operating profit | $2.2M | $1.2M | $996K | +83% |
| Costs & expenses | $5.6M | $6.6M | −$948K | -14% |
| Pre-tax earnings | $1.8M | $828K | $998K | +121% |
| Other expense, net | $368K | $370K | −$1K | -0.3% |
| Cost of revenue | $1.6M | $1.7M | −$63K | -4% |
| Research & development | $54K | $100K | −$46K | -46% |
| SG&A | $3.8M | $4.6M | −$839K | -18% |
| Other operating costs | $184K | $184K | $150 | +0.1% |
| Net earnings | $1.3M | $555K | $716K | +129% |
| Income tax | $555K | $273K | $282K | +103% |
| Depreciation & amortization | $241K | $244K | −$3K | -1% |
| Share-based compensation | $93K | $65K | $28K | +43% |
| Working capital & other | $462K | −$983K | $1.4M | — |
| Operating cash flow | $1.1M | $1.8M | −$704K | -38% |
| Free cash flow (OCF − capex) | $1.0M | $1.8M | −$773K | -43% |
| Capital expenditures | $102K | $33K | $69K | +212% |
Questions
How much did Cryo Cell International's revenue grow quarter over quarter in Q3 FY26?
Cryo Cell International's revenue rose $48K (+0.6%) from $7.8M in Q2 FY26 to $7.8M in Q3 FY26.
What drove Cryo Cell International's revenue change in Q3 FY26?
Public Banking +$89K (+190%); Processing and Storage Fees −$65K (-0.8%); Product +$25K (+174%).